Register


Create a profile to access all of our events, including options to sign up for our in person meetings and to view the online content from our past conferences!


Video Platform

View all the content from the last 12 months

MD Newsletter

Stay up to date with everything MD Education

Tickets & Events

Save your space and register for our future events

Select what applies to you




Login

Gaining access to MD Education’s premium offerings is only a button away! Enter your email and password to get educated.

MD-Education logo
Register / Login
We're evolving!

The website is currently being upgraded to include our new suite of offerings. Check back at the end of the month for a breakdown of our new services!


Questions? Contact us at:


office@md-education.com

Want Cookies?


Currently, we're using cookies for tracking purposes. By tracking, we mean what pages of MD Education you visit, what forms you submit and how you interact with our site. We do not sell this data to anybody. Currently, the Cookies we use are needed to collect form data through HubSpot.


If you'd like to see what we do with your data, head over to our Privacy Policy


3rd Annual

Thank you for registering to our ASH Satillite Symposium!

Please check your emails for registration confirmation.


AML-ALL

EU Focus Meeting

Updating Knowledge & Clinical Practice in 2024


Register / Login to view content


St. Ermin’s Hotel, London, UK

Friday 25 October 2024 - Saturday 26 October 2024

Presentations will be available online for 12 months

Meeting content distributed to 12,000+ HCPs

For more information get in touch!

=

Co-chair

Charlie Craddock, MD

Queen Elizabeth Hospital, Birmingham, UK

=

Co-chair

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX

=

Co-chair

Cristina Papayannidis, MD

University of Bologna, Italy

=

Co-chair

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX

Dear Colleagues and Friends,


We are delighted to have hosted the AML-ALL EU Focus Meeting 2024, multinational congress at St. Ermin’s Hotel, London, UK on the 25th of October, 2024 to the 26th of October, 2024.


This congress served as a pivotal platform for collaboration, advancing research and enhancing patient care.


For those who could not attend, all congress content is available online and will remain accessible for a full year, allowing healthcare professionals worldwide to benefit from the insights shared.


People stood in a circle, smiling, with a cup of water

Agenda & Faculty

AML-ALL EU Focus Meeting, Friday 25 October 2024 - Saturday 26 October 2024

7:00 AM

Registration Opens

7:45 AM

Opening remarks – Ryan Fitzpatrick, CEO, MD Education

Session I

8:00 AM

Research and progress in AML

=

Hagop Kantarjian, MD

MD Anderson Cancer Center, Houston, TX

8:20 AM

Practical approach to incorporating genomics in treatment decision making in Fit adult AML

=

Paresh Vyas, MD

University of Oxford, UK

8:40 AM

Incorporating MRD into treatment decision making in newly diagnosed AML, focus on NPM1 and FLT3 mutated AML

=

Christoph Röllig, MD

University Hospital Carl Gustav Carus, Dresden, Germany

9:00 AM

Current Status and Updates in the Diagnosis, Prognosis and Management of Secondary and Therapy Related AML

=

Priyanka Mehta, MD

University Hospital Bristol NHS Foundation Trust, UK

9:20 AM

Optimising transplant outcomes in high-risk AML?

=

Charlie Craddock, MD

Queen Elizabeth Hospital, Birmingham, UK

9:40 AM

Panel Discussion

10:00 AM

Coffee Break

Session II

10:20 AM

Biology of Ph pos ALL: new insights for a risk stratification?

=

Ilaria Iacobucci, MD

St. Jude Children’s Research Hospital, Memphis, TN

10:40 AM

How I treat Ph positive ALL in 2024: US

=

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX

11:00 AM

How I treat Ph positive ALL in 2024: Europe

=

Robin Foà, MD

University of Rome, Italy

11:20 AM

SCT in Ph+ ALL: is it still necessary?

=

Emmanuelle Clappier, MD

Hôpital Saint-Louis, France

11:40 AM

Open Issues in Pediatric ALL

=

Rob Pieters, MD

Princess Máxima Center, Utrecht, Netherlands

12:00 PM

Panel Discussion

12:20 PM

Lunch Break, Networking & Group Photo

Session III

1:10 PM

Which Patients with Newly Diagnosed AML Should Receive a Venetoclax Based Regimen in 2024

=

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX

1:30 PM

Menin Inhibitors in the Management of AML

=

Emma Searle, MD

The Christie NHS Foundation Trust, Manchester, UK

1:50 PM

Immunotherapeutic Strategies in AML

=

Marion Subklewe, MD

University Hospital of Munich, Germany

2:10 PM

Management of Disease Relapse in Fit and Unfit AML Patients

=

Alessandro Isidori, MD

Marche Nord Hospital, Pesaro, Italy

2:30 PM

Panel Discussion

2:50 PM

Coffee Break & Networking

Session IV

3:10 PM

SCT in Adult Ph Neg ALL: How, When and for Which Patients?

=

Anna Castleton, MD

The Christie NHS Foundation Trust, Manchester, UK

3:30 PM

CAR-T Cells in ALL: Progress and Pitfalls

=

Marion Subklewe, MD

University Hospital of Munich, Germany

3:50 PM

Debate: R/R Ph Neg ALL: CAR-T Cells or Antibodies?

=

CAR-T Cells

Claire Roddie, MD

University College London, UK

=

Antibodies

Nicolas Boissel, MD

Assistance Publique – Hôpitaux de Paris, France

4:10 PM

Panel & Debate Discussion

4:30 PM

Adjourn